No takes yet. Share an insight, caveat, or question.
This review details how multiparameter flow cytometry improves diagnosis and minimal residual disease monitoring in multiple myeloma patients, highlighting its importance for prognosis.
Leonardos et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: